Discussion Guides – SGLT2 Inhibitors | CardioSmart – American College of Cardiology
Use this resource to help optimize SGLT2 inhibitor use to improve outcomes in patients with heart failure, diabetes and chronic kidney disease.
Related Articles
Sex-Based Differences in Endovascular Thrombectomy Outcomes for Large Ischemic Stroke: A SELECT2 Subanalysis | Stroke
BACKGROUND: Several social and biological factors are shown to differentially affect stroke outcomes between men and women. We evaluated whether clinical outcomes and endovascular thrombectomy…
Paul “Bear” Bryant Awards 2024 Coach of the Year finalists named
HOUSTON, January 8, 2025 — Eight active college football coaches make up the American Heart Association’s 2024 Paul “Bear” Bryant Coach of the Year Award…
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study
Study evaluates the diagnostic yield of an advanced invasive diagnosis strategy in chronic coronary syndrome patients referred for invasive coronary angiography.
Boston Scientific enters IVL arms race with acquisition worth up to $664M
Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than…
Boston Scientific Announces Acquisition Agreement for Bolt Medical – Endovascular Today
January 8, 2025—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer
Preventing Contrast-induced Renal Failure: A Guide
Contrast-induced acute kidney injury (CI-AKI) is characterised by a rapid deterioration of renal function within a few days of parenteral administration of contrast media (CM)…
Genius and the CVD Polypill—A Step Toward Achieving Health Equity?
Over 2 decades ago, the idea for a polypill emerged as a plausible solution to reduce the global burden of cardiovascular disease (CVD) in low-…
Dietary restriction impacts health and lifespan of genetically diverse mice
Nature – Health effects of dietary restriction are uncoupled from longevity.
HeartTalk Video: Navigating Remote Monitoring in an Evolving Cardiac Care Landscape
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions.
Semaglutide Improves CV Outcomes in Patients With History of CABG and Obesity | JACC | AHA 2024
JACC Associate Editor Marc P. Bonaca, MD, FACC, speaks with author Subodh Verma, MD, PhD, and A. Michael A. Lincoff, MD, FACC, about this brief…
